Artivion Inc (AORT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $931.88M
Last updated: Nov 17, 2026 at 11:04 AM ET
Artivion Inc (AORT) Stock Forecast
Analysts expect Artivion (AORT) to earn $0.37 per share in the fiscal year ending Dec 31, 2026, on revenue of $489.30M. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.78, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 22.2% |
| Buy | 7 | 77.8% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 9
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 40.5% and revenue estimates rise 9.2%.
- Fiscal year ending Dec 31, 2026
- $0.37
- EPS consensus, revenue $489.30M
- Fiscal year ending Dec 31, 2027
- $0.52
- EPS consensus, revenue $534.46M
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.37 | $0.34 to $0.39 | 6 | $489.30M | $484.00M to $495.00M | 9 |
| Dec 31, 2027 | $0.52 | $0.36 to $0.72 | 7 | $534.46M | $524.10M to $558.10M | 9 |
Quarterly Estimates
The EPS consensus rises from -$0.05 for the quarter ending Dec 31, 2026 to $0.08 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.05 | -$0.10 to $0.05 | 11 | $125.14M | $115.74M to $131.25M | 11 |
| Mar 31, 2027 | $0.08 | $0.06 to $0.11 | 5 | $125.44M | $120.00M to $128.64M | 6 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 6 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 6 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 7.5% from $0.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.37 | $0.40 | $0.40 | $0.40 | $0.40 | -6.6% |
| Fiscal year ending Dec 31, 2027 | $0.52 | $0.75 | $0.75 | $0.75 | $0.75 | -30.4% |
| Quarter ending Mar 31, 2027 | $0.08 | $0.11 | $0.11 | $0.11 | $0.11 | -29.1% |
Frequently Asked Questions About AORT
What is the AORT stock forecast?
Consensus analyst estimates put Artivion's EPS at $0.37 for the fiscal year ending Dec 31, 2026, on revenue of $489.30M. The consensus rating from 9 analysts is Buy.
How do analysts rate AORT stock?
Of 9 analysts covering Artivion, 2 rate it Strong Buy, 7 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from AORT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.37, with estimates from $0.34 to $0.39 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.52, with estimates from $0.36 to $0.72 from 7 analysts.
What revenue do analysts expect from Artivion next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $489.30M, with estimates from $484.00M to $495.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $534.46M, with estimates from $524.10M to $558.10M.
How many analysts cover AORT?
9 analysts rate Artivion stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
AORT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts